Tempo Scan re-IPO

Tempo Scan share sale increased to $229 million

Robust demand from high-quality institutions allows the majority owner to sell more shares than planned in Tempo Scan, an Indonesian pharmaceutical and consumer products company.

<div style="text-align: left;"> Tempo Scan's $229 million offering is the biggest equity deal in Indonesia this year </div>

May 11, 2012

The controlling shareholder of Indonesia’s Tempo Scan Pacific has raised Rp2.12 trillion ($229 million) from the sale of existing shares through a fully marketed transaction that was enlarged beyond the previously announced deal size, pushing the free-float above 20%.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.